Cloudmed

Cloudmed

Cloudmed traces its roots to R1 RCM, a publicly traded revenue cycle management firm founded in 2003. R1 acquired Cloudmed's predecessor, Revint, and operates the revenue intelligence division as an Atlanta-based subsidiary, serving 95 of the top 100 US health systems (per the firm, 2025). The wealth supporting Cloudmed is not disclosed, as it is a corporate entity. The firm focuses on healthcare revenue cycle management, deploying its CloudmedAI platform across three suites: Acceleration (claims and denials), Optimization (underpayment recovery), and Government Navigation (compliance and reimbursement). Asset classes served include hospital systems, physician groups, and ambulance providers. Confirmed capabilities include charge capture and denial management, with underpayment recovery generating $8M in identified revenue for one health system in its first year (per a 2024 case study). Operations are US-only. R1 reported over $2B in annual revenue for 2024 (per R1 annual filing, 2024). Cloudmed employs no publicly listed investment professionals; the parent R1 RCM employs approximately 20,000 staff globally. The firm's Chicago office serves as corporate HQ; no additional offices are disclosed. R1 maintains an ESG program but no separate philanthropic foundation is listed. Cloudmed's structural differentiator is its integration into R1 RCM, a large-cap public company, which provides scale and operating cash flow not typical of private revenue cycle firms. This gives the firm access to capital for AI development and cross-selling across a vast hospital client base.